1- more specific drugs such as subtypes of specified sodium blockers and local anesthetics for the thoracic cavity and C fibers will go to the commercial and routine use. Thus a combination of drugs which are effective and specified for the C and A delta will be used. These drugs may be prescribed intravenously, but will select the specific receptors on the thoracic cavity , but it won't be enough and needs much more considerations.
2-Advances in hypnotherapy in the future may change the way of anesthesizing and pain therapy of patients.